Eybelis/Eybelis-S Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Concise Prescribing Info

Contents

Omidenepag isopropyl

Indications/Uses

Open-angle glaucoma & ocular HTN.

Click to view Eybelis/Eybelis-S detailed prescribing information

Dosage/Direction for Use

Recommended & max dose: 1 drop in the affected eye(s) once daily.

Click to view Eybelis/Eybelis-S detailed prescribing information

Overdosage

View Eybelis/Eybelis-S overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Patients w/ aphakic eyes or intraocular lens inserted eyes. Concomitant use w/ tafluprost.

Click to view Eybelis/Eybelis-S detailed prescribing information

Special Precautions

Macular edema including cystoid macular edema; worsening vision. May develop temporary blurred vision or photophobia after instillation. Active ocular inflammation including iritis/uveitis; angle-closure glaucoma. Remove contact lenses before using the product & reinsert after 15 min or longer afterwards. Administer at least 5 min apart if >1 topical ophth product is being used. Not to drive or operate machines until symptoms of temporary blurred vision or photophobia disappear. Pregnancy & lactation. Childn & adolescents.

Click to view Eybelis/Eybelis-S detailed prescribing information

Use In Pregnancy & Lactation

Click to view Eybelis/Eybelis-S detailed prescribing information

Adverse Reactions

Conjunctival hyperemia. Corneal thickening, macular edema (including cystoid macular edema), iritis (anterior chamber cells & flare), eye pain, photophobia, ocular discomfort (eg, irritation), corneal epithelial disorders.

Click to view Eybelis/Eybelis-S detailed prescribing information

Drug Interactions

Concomitant use w/ tafluprost & other glaucoma/ocular HTN medications eg, timolol maleate.

Click to view Eybelis/Eybelis-S detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Eybelis/Eybelis-S detailed prescribing information

Storage

View Eybelis/Eybelis-S storage conditions for details to ensure optimal shelf-life.

Description

View Eybelis/Eybelis-S description for details of the chemical structure and excipients (inactive components).

Action

View Eybelis/Eybelis-S mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiglaucoma Preparations

ATC Classification

S01EX06 - omidenepag ; Belongs to the class of other antiglaucoma preparations.

Thai FDA Category

D, S

Presentation/Packing

Form

Eybelis ophth soln 0.002%

Packing/Price

2.5 mL x 1's

Form

Eybelis-S ophth soln 0.002%

Packing/Price

((0.3 mL)) 30 × 1's

Eybelis/Eybelis-S

omidenepag

Manufacturer:

Santen

Distributor:

DKLL

Marketer:

Santen